Cooper Companies | COO - Przychody Ze Sprzedaży

Cena Akcji
71.40
Dzienna Zmiana
-0.10 -0.14%
Miesięcznie
-14.92%
Rocznie
-12.10%
Q2 Prognozy TE
67.68




Obroty Zmiana Data
Abbott USD 11.46B 90M 2025-12
Align Technology USD 1.05B 54.3M 2025-12
AtriCure USD 140.5M 6.2M 2025-12
Avanos Medical USD 180.9M 3.1M 2025-12
Bausch Health Companies USD 2.8B 120M 2025-12
Baxter International USD 2.97B 130M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Boston Scientific USD 5.29B 220M 2025-12
Cooper Companies USD 1.02B 41.1M 2025-12
Dentsply International USD 961M 57M 2025-12
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.57B 20M 2025-12
Globus Medical USD 826.4M 57.4M 2025-12
Haemonetics USD 338.97M 11.97M 2025-12
Hologic USD 1.05B 0 2025-12
Inogen USD 74.93M 504K 2024-09
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
Intuitive Surgical USD 2.87B 360M 2025-12
J&J USD 24.6B 610M 2025-12
Medtronic USD 9B 39M 2026-01
Merit Medical Systems USD 393.9M 9.7M 2025-12
Novartis USD 13.86B 498M 2025-12
ResMed USD 1.4B 100M 2025-12
STAAR Surgical USD 239.4M 144.7M 2025-12
Steris USD 1.5B 470M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teleflex USD 568.98M 344.02M 2025-12
Utah Medical Products USD 9.04M 955K 2025-12
Zimmer Biomet Holdings USD 2.24B 240M 2025-12